Sativex, a drug derived from the cannabis plant for multiple sclerosis pain

May 2005

Canadians will soon be able to get Sativex, a drug derived from the cannabis plant for multiple sclerosis pain.

Canada is the first country to approve this drug.

Interestingly, Canada has one of the highest rates of multiple sclerosis in the world.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Sativex, a drug derived from the cannabis plant for multiple sclerosis pain
Neurology & Pain New Health Canada restrictions on Celebrex
Antithrombotics prescribing 1300 mg/day of aspirin to prevent recurrent stroke
Antithrombotics patients are caught by surprise when fad diets or special foods interfere with their warfarin therapy
Cholesterol Extended-release Niaspan is the first prescription-only niacin
Cholesterol whether the Canadian dyslipidemia guidelines are causing too many of the WRONG people to get statins
Women's Health Plan B to Schedule II
Women's Health whether pharmacists have the right to refuse to dispense emergency contraception
Thyroid Disorders Should patients with hypothyroidism be treated with both levothyroxine (Synthroid, etc) AND liothyronine (Cytomel)
Thyroid Disorders whether levothyroxine products (Synthroid, Eltroxin) are interchangeable
Bisphosphonates Boniva (ibandronate), a once-MONTHLY bisphosphonate for osteoporosis
Bisphosphonates new warnings that bisphosphonates may cause death of bone tissue in the jaw
Infectious Diseases new vaccine called FSME-IMMUN in Canada for the prevention of tick-borne encephalitis viral infection
Supplements Probiotics may be useful for some types of diarrhea